Carolina (@carolinagotera) 's Twitter Profile
Carolina

@carolinagotera

Pneumologist. COPD & LC Screening @Hospital_FJD. European Diploma in Adult Respiratory Medicine (HERMES) @EuroRespSoc.

ID: 515187864

linkhttp://www.fjd.es calendar_today05-03-2012 07:04:50

4,4K Tweet

957 Followers

1,1K Following

ERS (@eurorespsoc) 's Twitter Profile Photo

For #WorldTBDay 2025, we have produced an @ERSPublications round-up of articles and resources relating to TB. View the collection online: bit.ly/4iGbtRt

For #WorldTBDay 2025, we have produced an @ERSPublications round-up of articles and resources relating to TB. 
 
View the collection online: bit.ly/4iGbtRt
Sarah Heili-Frades Zimmermann MD, PhD (@sheilisarah) 's Twitter Profile Photo

HOLAAAA!!! Como Directora del comité de Innovación de SeparRespira os invito a una Jornada de Innovación en Salud que es un must y que se celebrará el 9 de mayo en mi hospital querido Fundación Jiménez Díaz !! Quedan pocas plazas. Os dejo el programa y la inscripción que es gratuita ⬇️!

HOLAAAA!!! Como Directora del comité de Innovación de <a href="/SeparRespira/">SeparRespira</a> os invito a una Jornada de Innovación en Salud que es un must y que se celebrará el 9 de mayo en mi hospital querido <a href="/Hospital_FJD/">Fundación Jiménez Díaz</a> !! Quedan pocas plazas. Os dejo el programa y la inscripción que es gratuita ⬇️!
ThoraxBMJ (@thoraxbmj) 's Twitter Profile Photo

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) thorax.bmj.com/content/early/… @michalshteinbe1, @profjdchalmers

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) thorax.bmj.com/content/early/…  @michalshteinbe1, @profjdchalmers
Felipe Villar Álvarez (@fvillarleon) 's Twitter Profile Photo

Ayer cierre de congreso de Neumomadrid con premio a la enfermería de la UCCRA Fundación Jiménez Díaz.🏆Orgullo! Por la mañana presentación proyecto y resultados del estudio de reduccion de contaminación y mejora salud con Ayuntamiento Madrid, y del documento de vacunación en paciente respiratorio💉

Ayer cierre de congreso de <a href="/NeumoMadrid/">Neumomadrid</a> con premio a la enfermería de la UCCRA <a href="/Hospital_FJD/">Fundación Jiménez Díaz</a>.🏆Orgullo! Por la mañana presentación proyecto y resultados del estudio de reduccion de contaminación y mejora salud con <a href="/MADRID/">Ayuntamiento Madrid</a>, y del documento de vacunación en paciente respiratorio💉
ERS publications (@erspublications) 's Twitter Profile Photo

ERR: Neutrophilic inflammation plays a key role in the pathophysiology of bronchiectasis. As there are no licensed therapies to treat bronchiectasis, novel therapies that target neutrophilic inflammation may be beneficial for patients with the disease. bit.ly/3EcbqgK

ERR: Neutrophilic inflammation plays a key role in the pathophysiology of bronchiectasis. As there are no licensed therapies to treat bronchiectasis, novel therapies that target neutrophilic inflammation may be beneficial for patients with the disease. bit.ly/3EcbqgK
Fundación Jiménez Díaz (@hospital_fjd) 's Twitter Profile Photo

#Agenda 📆 El viernes 9 de mayo acogeremos la celebración de la Jornada SEPAR Innova en Enfermedades Respiratorias. Una cita que no será solo un evento formativo, sino una experiencia inmersiva diseñada para provocar el intercambio de ideas y soluciones disruptivas

#Agenda 📆 El viernes 9 de mayo acogeremos la celebración de la Jornada SEPAR Innova en Enfermedades Respiratorias. Una cita que no será solo un evento formativo, sino una experiencia inmersiva diseñada para provocar el intercambio de ideas y soluciones disruptivas
ERS publications (@erspublications) 's Twitter Profile Photo

ERJ Open Res: Multimorbid severe COPD patients need to be treated with a complementary systemic approach. In this way, the patient, not only the airway disease, will be treated comprehensively, as two effects (metabolic and pulmonary) are better than one. bit.ly/3PHoygt

ERJ Open Res: Multimorbid severe COPD patients need to be treated with a complementary systemic approach. In this way, the patient, not only the airway disease, will be treated comprehensively, as two effects (metabolic and pulmonary) are better than one. bit.ly/3PHoygt
ERS publications (@erspublications) 's Twitter Profile Photo

ERJ Open Research: Chronic cough is relatively common. This study highlights the complexity of chronic cough management and the need for further research and diagnostic tools to improve patient outcomes. bit.ly/3XPIyCc

ERJ Open Research: Chronic cough is relatively common. This study highlights the complexity of chronic cough management and the need for further research and diagnostic tools to improve patient outcomes. bit.ly/3XPIyCc
NEJM (@nejm) 's Twitter Profile Photo

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, may lower the rate of pulmonary exacerbations in patients with bronchiectasis. Findings from the ASPEN phase 3 trial are summarized in a short video. nej.md/4jhMNPA

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, may lower the rate of pulmonary exacerbations in patients with bronchiectasis. Findings from the ASPEN phase 3 trial are summarized in a short video. nej.md/4jhMNPA
Nicole Hass (@nicole_european) 's Twitter Profile Photo

El #apagon afecta especialmente a nuestros pacientes #electrodependientes de la comunidad respiratoria. La asociación de pacientes con #EPOC, Asoc. Pacientes con EPOC tiene muchos pacientes con #oxigenoterapia . Compartimos las recomendaciones de nuestro asesor de neumologia, Dr Felipe Villar Álvarez

El #apagon afecta especialmente a nuestros pacientes #electrodependientes de la comunidad respiratoria.
La asociación de pacientes con #EPOC, <a href="/apepoc_es/">Asoc. Pacientes con EPOC</a> tiene muchos pacientes con #oxigenoterapia .
Compartimos las recomendaciones de nuestro asesor de neumologia, Dr <a href="/fvillarleon/">Felipe Villar Álvarez</a>
James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

Mepolizumab reduces exacerbations by 21% in eosinophilic COPD patients treated for up to 104 weeks. Patients included regardless of chronic bronchitis history Congratulations Ian Pavord and colleagues nejm.org/doi/full/10.10…

Juan Gómez Rivas (@jgomezrivas) 's Twitter Profile Photo

Hola 👋🏼 con mucha ilusión ¡Me presento como candidato a Director de Actividades Científicas de la Asociación Española de Urología (AEU)! Te invito a conocer mi propuesta basada en una visión científica e integradora, orientada a fortalecer tu formación y carrera profesional. 💪🏼

James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

Just published! Important new clinical statement on Aspergillus lung disease from British Thoracic Society (BTS) Congratulations to everyone involved including our own David Connell thorax.bmj.com/content/80/Sup…

Amelia Carro — Instituto Corvilud (@icorvilud) 's Twitter Profile Photo

OBESITY-INDUCED CARDIOMYOPATHY ⚖️Epicardial adipose tissue (EAT): a modifiable risk factor ⚖️EAT changes with age and in pathological conditions: early detection is mandatory ⚖️Mechanical, chemical & electric effects➡️CVD ⚖️GLP1ar & SGLT2 inhibitors impact EAT pathologic effects

OBESITY-INDUCED CARDIOMYOPATHY
⚖️Epicardial adipose tissue (EAT): a modifiable risk factor 
⚖️EAT changes with age and in pathological conditions: early detection is mandatory
⚖️Mechanical, chemical &amp; electric effects➡️CVD
⚖️GLP1ar &amp; SGLT2 inhibitors impact EAT pathologic effects
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

The PREVENT equations effectively predict cardiovascular disease risk overall, including for individuals with elevated lipoprotein(a). ja.ma/4jRVM9P

The PREVENT equations effectively predict cardiovascular disease risk overall, including for individuals with elevated lipoprotein(a). 

ja.ma/4jRVM9P
Dr Alo, DO, FACC (@mohammedalo) 's Twitter Profile Photo

Potential New Dyslipidemia Treatments 1️⃣ Inclisiran reduced LDL by 44.1% and apolipoproteins by 37.5% in hypercholesterolemia. 2️⃣ Lepodisiran and Olpasiran reduced apolipoproteins by 75.7% and LDL by 16.3% in hyperlipoproteinemia(a). 3️⃣ ARO-APOC3 and Plozasiran lowered VLDL

Potential New Dyslipidemia Treatments

1️⃣ Inclisiran reduced LDL by 44.1% and apolipoproteins by 37.5% in hypercholesterolemia.

2️⃣ Lepodisiran and Olpasiran reduced apolipoproteins by 75.7% and LDL by 16.3% in hyperlipoproteinemia(a).

3️⃣ ARO-APOC3 and Plozasiran lowered VLDL
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Most viewed this week from JAMA Cardiology: Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction similar to that observed in tobacco smokers. ja.ma/45JP4yV

Most viewed this week from <a href="/JAMACardio/">JAMA Cardiology</a>: 

Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction similar to that observed in tobacco smokers.  

ja.ma/45JP4yV
ERS publications (@erspublications) 's Twitter Profile Photo

ERJ Open Research: DPP-4 inhibitor use is associated with a significantly lower risk of mortality, cardiovascular events, respiratory complications and lung cancer in patients with COPD and T2D. Patients with COPD may benefit from DPP-4 inhibitors. bit.ly/4fUvzGa

ERJ Open Research: DPP-4 inhibitor use is associated with a significantly lower risk of mortality, cardiovascular events, respiratory complications and lung cancer in patients with COPD and T2D. Patients with COPD may benefit from DPP-4 inhibitors. bit.ly/4fUvzGa
Sarah Heili-Frades Zimmermann MD, PhD (@sheilisarah) 's Twitter Profile Photo

Buenas tardes, con tremendo orgullo comparto el premio que más me llena, el que nos dan nuestros pacientes. Gracias a vosotros por confiar en la UCIR del Fundación Jiménez Díaz . Gracias de corazón de parte de Pilar, Alba, Itziar y yo misma.

Buenas tardes, con tremendo orgullo comparto el premio que más me llena, el que nos dan nuestros pacientes. Gracias a vosotros por confiar en la UCIR del <a href="/Hospital_FJD/">Fundación Jiménez Díaz</a> . Gracias de corazón de parte de Pilar, Alba, Itziar y yo misma.